A dose range-finding study to assess the efficacy and safety of multiple dose levels of AZD8630 administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA).
Asthma
A dose range-finding study to assess the efficacy and safety of multiple dose levels of AZD8630 administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA).
A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations
-
Research Site, Mesa, Arizona, United States, 85213
Research Site, Huntington Beach, California, United States, 92647
Research Site, La Mesa, California, United States, 91942
Research Site, Laguna Niguel, California, United States, 92677
Research Site, Lancaster, California, United States, 93534
Research Site, Long Beach, California, United States, 90815
Research Site, San Diego, California, United States, 92120
Research Site, San Jose, California, United States, 95117
Research Site, Aurora, Colorado, United States, 80045
Research Site, Englewood, Colorado, United States, 80110
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 80 Years
ALL
No
AstraZeneca,
Njira Lugogo, PRINCIPAL_INVESTIGATOR, Univeristy of Michigan Hospital, Ann Arbor, MI, US
2026-04-06